The Relationship Between Tumor Inflammatory Cell Infiltrate and Outcome in Patients with Pancreatic Ductal Adenocarcinoma

被引:58
|
作者
Jamieson, Nigel B. [1 ,2 ]
Mohamed, Mohamed [2 ]
Oien, Karin A. [3 ]
Foulis, Alan K. [3 ]
Dickson, Euan J. [1 ]
Imrie, Clem W. [1 ]
Carter, C. Ross [1 ]
McKay, Colin J. [1 ]
McMillan, Donald C. [2 ]
机构
[1] Glasgow Royal Infirm, W Scotland Pancreat Unit, Glasgow G4 0SF, Lanark, Scotland
[2] Glasgow Royal Infirm, Univ Dept Surg, Glasgow G4 0SF, Lanark, Scotland
[3] Glasgow Royal Infirm, Univ Dept Pathol, Glasgow G4 0SF, Lanark, Scotland
关键词
PROGNOSTIC VALUE; SYSTEMIC INFLAMMATION; CURATIVE RESECTION; T-CELLS; CANCER; SURVIVAL; LYMPHOCYTES; CACHEXIA; SCORE; MANAGEMENT;
D O I
10.1245/s10434-012-2370-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumor-associated inflammatory cell infiltrate is recognized to have prognostic value in various common solid tumors. However, the prognostic value of the tumor inflammatory cell infiltrate has not been established in pancreatic ductal adenocarcinoma (PDAC) nor has its relationship with the systemic inflammatory response. Retrospective study was made of 173 patients who underwent surgery between 1997 and 2009. Routine pathology specimens were scored according to density of the tumor inflammatory cell infiltrate, and biochemical data were collected preoperatively. Low-grade tumor inflammatory cell infiltrate was associated with earlier tumor recurrence (P < 0.001) and particularly in the liver (P = 0.027). It was also associated with T3 tumors (P < 0.05), lymph node involvement (P < 0.05), and resection margin involvement (P < 0.05). On univariate survival analysis, age < 65 years (P < 0.05), mGPS (P < 0.001), increased tumor stage (P < 0.01), nodal involvement (P < 0.01), size (P < 0.05), grade (P < 0.05), perineural invasion (P < 0.05), venous invasion (P < 0.01), resection margin involvement (P a parts per thousand currency sign 0.001), vascular reconstruction (P < 0.05), and no adjuvant chemotherapy (P < 0.05) were associated with poor survival. In contrast, high-grade tumor inflammatory cell infiltrate was associated with better survival (P < 0.001). On multivariate survival analysis, mGPS [hazard ratio (HR): 1.77, 95 % confidence interval (95 % CI): 1.19-2.62, P = 0.005], tumor stage (HR: 2.21, 95 % CI: 1.16-4.23, P = 0.016), resection margin involvement (HR: 2.19, 95 % CI: 1.41-3.44, P = 0.001), venous invasion (HR: 1.79, 95 % CI: 1.22-2.63, P = 0.003), tumor inflammatory cell infiltrate (HR: 0.37, 95 % CI: 0.25-0.55, P = 0.0001), and adjuvant chemotherapy (P = 0.04) were independently prognostic. The results of the study show, for the first time, that the presence of a high-grade tumor inflammatory cell infiltrate is an independent predictor of prolonged overall survival following resection for PDAC. Furthermore, measures of the local and the systemic inflammatory response were inversely associated.
引用
收藏
页码:3581 / 3590
页数:10
相关论文
共 50 条
  • [21] Relationships between physical and immunological tumor microenvironment in pancreatic ductal adenocarcinoma
    Igata, Yu
    Kojima, Motohiro
    Suzuki, Toshiyuki
    Ishii, Genichiro
    Morisue, Ryo
    Suzuki, Toshihiro
    Kudo, Masashi
    Sugimoto, Motokazu
    Kobayashi, Shin
    Martin, John D.
    Stylianopoulos, Triantafyllos
    Cabral, Horacio
    Kano, Mitsunobu R.
    Konishi, Masaru
    Gotohda, Naoto
    CANCER SCIENCE, 2023, 114 (09) : 3783 - 3792
  • [22] Inflammatory Cytokines and Radiotherapy in Pancreatic Ductal Adenocarcinoma
    Ng, Sylvia S. W.
    Dawson, Laura A. A.
    BIOMEDICINES, 2022, 10 (12)
  • [23] Identification of Inflammatory Subtypes of Pancreatic Ductal Adenocarcinoma
    不详
    PANCREAS, 2022, 51 (07) : 857 - 858
  • [24] Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma
    Wang, Li
    Wu, Huanwen
    Wang, Lili
    Lu, Junliang
    Duan, Huanli
    Liu, Xuguang
    Liang, Zhiyong
    DIAGNOSTIC PATHOLOGY, 2016, 11
  • [25] Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma
    Li Wang
    Huanwen Wu
    Lili Wang
    Junliang Lu
    Huanli Duan
    Xuguang Liu
    Zhiyong Liang
    Diagnostic Pathology, 11
  • [26] Outcome of the Patients With Pancreatic Ductal Adenocarcinoma and Borderline Operable Vascular Invasion
    Seppanen, H.
    Juuti, A.
    Mustonen, H.
    Haapamaki, C.
    Nordling, S.
    Siren, J.
    Haglund, C.
    Kiviluoto, T.
    PANCREAS, 2013, 42 (08) : 1380 - 1381
  • [27] Pancreatic Collision Tumor of Ductal Adenocarcinoma and Neuroendocrine Tumor
    Wang, Yuchen
    Gandhi, Seema
    Basu, Anupam
    Ijeli, Anthonia
    Kovarik, Paula
    Sekosan, Marin
    Demetria, Melchor
    ACG CASE REPORTS JOURNAL, 2018, 5
  • [28] ALCAM as a Novel Circulating Tumor Cell Marker for Pancreatic Ductal Adenocarcinoma
    Jacob, H. K. C.
    Signorelli, R.
    Richard, J. L. C.
    Giret, T. M.
    Kashuv, T.
    Gomez, B. A.
    Middleton, A.
    Lavania, S.
    Dudeja, V.
    Saluja, A. K.
    PANCREAS, 2020, 49 (10) : 1413 - 1413
  • [29] Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment
    Shibuya, Kendall C.
    Goel, Vikas K.
    Xiong, Wei
    Sham, Jonathan G.
    Pollack, Seth M.
    Leahy, Allison M.
    Whiting, Samuel H.
    Yeh, Matthew M.
    Yee, Cassian
    Riddell, Stanley R.
    Pillarisetty, Venu G.
    PLOS ONE, 2014, 9 (05):
  • [30] An Inflammatory Response Related Gene Signature Associated with Survival Outcome and Gemcitabine Response in Patients with Pancreatic Ductal Adenocarcinoma
    Xiao, Zhijun
    Li, Jinyin
    Yu, Qian
    Zhou, Ting
    Duan, Jingjing
    Yang, Zhen
    Liu, Cuicui
    Xu, Feng
    FRONTIERS IN PHARMACOLOGY, 2021, 12